Mobia Medical (MOBI)
Implanted neurostimulation therapy paired with rehabilitation for chronic stroke recovery.
Something off on this page? Send us feedback.
Sells the Vivistim implanted neurostimulation system and accessories to U.S. stroke hospitals, pairing vagus-nerve stimulation with rehabilitation for adults with chronic ischemic-stroke arm impairment. Revenue is entirely tied to this single product and care pathway, where hospital adoption and payor coverage are essential.
Markets the Vivistim Paired Vagus Nerve Stimulation System, an implanted Class III device used with physical or occupational therapy to improve hand and arm motor function in adults with chronic ischemic-stroke impairment. Systems and accessories are sold to U.S. stroke hospitals, where implanting clinicians, therapists, referrals, and patient education must coordinate the care pathway.
Builds adoption through territory managers that establish hospital programs and licensed therapy-development specialists that educate rehabilitation sites, while registry and clinical work support coverage and guideline development. All revenue comes from the same product and United States market; demand depends on reimbursement, prior authorization, willingness to undergo implantation, ongoing FDA requirements, and single-source suppliers for critical implant components.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $177.1M · Total debt $8.4M · Total assets $195.3M · Shareholders' equity $172.6M
- Revenue
- $13.5M
- Operating income
- −$17.9M
- Net income
- −$21.0M
No dividends on record.
| Institutions | 25.83% | 8.59M shares | |
|---|---|---|---|
| 43 holders · as of Jun 30, 2026 | |||
| Other | 74.17% | 24.66M shares | |
| remainder | |||
33.25M company shares as of Aug 21, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Sr One Capital Management, LPInstitution | 5.97% | 1.99M | as of Jun 30, 2026 |
Farallon Capital Management LLCInstitution | 3.39% | 1.13M | as of Jun 30, 2026 |
Avidity Partners Management LPInstitution | 2.40% | 798,282 | as of Jun 30, 2026 |
Deerfield Management Company, L.P. (Series C)Institution | 2.02% | 670,752 | as of Jun 30, 2026 |
Abrdn PLCInstitution | 1.76% | 584,570 | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
